Biotechnology Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity Why Is Protara Therapeutics Stock Trading Lower On Friday? – Protara Therapeutics (NASDAQ:TARA) Read more
Biotechnology Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows – GSK (NYSE:GSK), Pfizer (NYSE:PFE) Read more
Biotechnology Osmol Therapeutics Appoints Ron Weitzman, M.D., as Interim Chief Medical Officer Read more
Stockmarkets Australia’s Star Entertainment beats interim profit estimate, shares jump Reuters via biedexmarkets.com Read more